GSK, Moderna End COVID Vaccine Patent Fight In Delaware
GlaxoSmithKline and Moderna dismissed two Delaware federal patent suits Friday over Moderna's COVID-19 and respiratory syncytial virus vaccines, following a broader settlement in which the companies agreed to license patents to...To view the full article, register now.
Already a subscriber? Click here to view full article